The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
292.00
-0.30 (-0.10%)
At close: Apr 24, 2025
15.05%
Market Cap 9.12B
Revenue (ttm) 11.48B
Net Income (ttm) 593.81M
Shares Out 31.24M
EPS (ttm) 19.01
PE Ratio 15.36
Forward PE 12.64
Dividend 6.30 (2.16%)
Ex-Dividend Date Oct 28, 2024
Volume 20,326
Average Volume 33,831
Open 292.10
Previous Close 292.30
Day's Range 291.50 - 297.10
52-Week Range 223.50 - 384.80
Beta 0.20
RSI 46.27
Earnings Date Apr 24, 2025

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Employees 4,200
Stock Exchange Dhaka Stock Exchange
Ticker Symbol IBNSINA
Full Company Profile

Financial Performance

In 2024, DSE:IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.

Financial Statements

News

There is no news available yet.